5 September 2024 - Merck announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for Welireg (belzutifan) on 30 August. 

The Alliance negotiates on behalf of the provinces, territories, and federal drug programs serving as a critical step in bringing Welireg closer to public reimbursement.

Read Merck press release